Portfolio company
Nygen
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
1Cell.Ai
The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
Scailyte
This company develops artificial intelligence software for single-cell data analysis and biomarker discovery for pharmaceutical, clinical and academic research customers.
Betteromics
This company develops a clinical-grade software platform for life science professionals to integrate and analyse complex data using artificial intelligence and computational techniques.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
